Virtual Reality for Depression in Alzheimer's Disease
(VRN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Behavioural and psychological symptoms of dementia (BPSD), such as depression affect up to 90% patients with dementia. Non-pharmacological treatment of BPSD, can be difficult to access, require caregiver support, travel, and often have long waiting lists. Virtual reality (VR) is an innovative, portable, immersive, and accessible technology which can be used in-home. More information is required on the feasibility of using VR in-home with older adults with dementia.Our study will offer a 4-week program of 15-minutes sessions, twice per week nature-based VR program for BPSD delivered in-home by virtual reality (VR). Additionally, caregivers will have the option of taking part in the study and provide feedback regarding the VR intervention. If successful, this project has the potential to prolong aging in place for individuals with BPSD, as BPSD is a significant factor in institutionalization.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Is virtual reality safe for people with Alzheimer's and other cognitive impairments?
Research shows that virtual reality is generally safe for older adults, including those with Alzheimer's and cognitive impairments. In studies, participants experienced no negative side effects like dizziness or disorientation, and they tolerated the headsets well, often enjoying the experience.12345
How does the Nature-based Virtual Reality Intervention treatment for depression in Alzheimer's disease differ from other treatments?
The Nature-based Virtual Reality Intervention is unique because it uses immersive virtual reality experiences to engage patients with Alzheimer's disease, potentially offering a non-drug approach to alleviate depression by simulating calming natural environments, which may differ from traditional pharmacological or psychosocial treatments.678910
Who Is on the Research Team?
Eric Brown, MD
Principal Investigator
CAMH and UofT
HARMEHR SEKHON, PhD
Principal Investigator
CAMH and McGill/St. Mary's Research Centre
Are You a Good Fit for This Trial?
This trial is for individuals with Alzheimer's Disease who are experiencing depression. It's designed to test if nature-based virtual reality (VR) can help reduce their symptoms without needing to leave home. Caregivers of participants may also join the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a nature-based VR program for BPSD, delivered in-home, with 15-minute sessions twice per week
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Nature-based Virtual Reality Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre for Addiction and Mental Health
Lead Sponsor
St. Mary's Research Center, Canada
Collaborator